FDA Inspection 854124 — Ursapharm Arzneimittel GmbH

Ursapharm Arzneimittel GmbH — FEI 3004978466

The FDA completed an inspection of Ursapharm Arzneimittel GmbH on Sep 13, 2013 in Saarbrucken. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 13, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saarbrucken (Germany)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.